SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-025399
Filing Date
2021-05-10
Accepted
2021-05-10 17:07:31
Documents
92
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0321_cleneinc.htm 10-Q 596541
2 CERTIFICATION f10q0321ex31-1_cleneinc.htm EX-31.1 9642
3 CERTIFICATION f10q0321ex31-2_cleneinc.htm EX-31.2 9736
4 CERTIFICATION f10q0321ex32-1_cleneinc.htm EX-32.1 4121
5 CERTIFICATION f10q0321ex32-2_cleneinc.htm EX-32.2 4100
  Complete submission text file 0001213900-21-025399.txt   4949814

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE clnn-20210331.xml EX-101.INS 712581
7 XBRL SCHEMA FILE clnn-20210331.xsd EX-101.SCH 92619
8 XBRL CALCULATION FILE clnn-20210331_cal.xml EX-101.CAL 35756
9 XBRL DEFINITION FILE clnn-20210331_def.xml EX-101.DEF 344037
10 XBRL LABEL FILE clnn-20210331_lab.xml EX-101.LAB 639437
11 XBRL PRESENTATION FILE clnn-20210331_pre.xml EX-101.PRE 358452
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39834 | Film No.: 21908309
SIC: 2834 Pharmaceutical Preparations